Top Asthma & COPD Drugs companies

The 6 key players our Asthma & COPD Drugs report profiles, and other companies free public records show in this market.

Key players in Asthma & COPD Drugs

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Also active in Asthma & COPD Drugs

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Source: Drugs@FDA, US approvals each company holds for medicines on the market whose FDA label lists this use. Retrieved 13 Nov 2026.

Top trial sponsors in Asthma & COPD Drugs

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. AstraZeneca 43 active trials on ClinicalTrials.gov (opens in a new tab)
  2. GSK PLC 19 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Sanofi 9 active trials on ClinicalTrials.gov (opens in a new tab)
  4. Chiesi 8 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Inmunotek S.L. 7 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Haisco Pharmaceutical Group Co., Ltd. 7 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Guangdong Hengrui Pharmaceutical Co., Ltd 7 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Pfizer Inc. 6 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Asthma & COPD Drugs reports by place

All 33 places for Asthma & COPD Drugs

Get the full Asthma & COPD Drugs report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.